Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5030 of 5804
-
Dentists test two Pulp-Saving methods for Kids' deep cavities
Disease control CompletedThe purpose of this randomized controlled clinical trial was to compare the clinical and radiographic outcomes of indirect pulp treatment (IPT) and direct pulp capping (DPC) using mineral trioxide aggregate (MTA) in deep carious primary molars. Children with deep dentin caries in…
Phase: NA • Sponsor: Ankara University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New pill shows promise for Hard-to-Treat blood cancer in early japanese study
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of ME-401 in the treatment of Japanese participants with Relapsed or Refractory indolent B-Cell Non-Hodgkin's Lymphoma and to continue administraion of ME-401 to patients with relapsed or refr…
Phase: PHASE1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can senior companions ease the burden of dementia care?
Knowledge-focused CompletedThe inability of healthcare systems to effectively manage Alzheimer's disease and related dementias (ADRD) often results in families remaining unaware of important community-based, long-term services and supports (LTSS) that could help to mitigate the negative effects of cognitiv…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New hearing test could uncover 'Hidden' hearing loss without needles or anesthesia
Diagnosis Recruiting nowAcoustic overexposure can induced temporary or hearing loss. Usually hearing loss is associated with cochlear cell damages. Recently, a new pathological entity was described and called "hidden hearing loss". In animal model, the histopathology revealed a selective reduction in th…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Sitting less, walking more: simple breaks may cut diabetes and heart risk
Knowledge-focused CompletedThe purpose of this study is to examine whether breaking up prolonged sitting with short regular bouts of walking can reduce blood sugar and cholesterol levels after eating, which are risk markers for Type 2 diabetes and heart disease. This study will compare these responses in n…
Phase: NA • Sponsor: University of Bedfordshire • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
One pill to tackle two heart risks: triple combo tested
Disease control CompletedThe goal of this study was to assess the efficacy and safety of FDC therapy with triple therapy of Telmisartan 40 mg/Amlodipine 5 mg/Rosuvastatin 10mg in Korean patients with both hypertension and dyslipidemia.
Phase: PHASE4 • Sponsor: Hyo-Soo Kim • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain games and movement may boost MS memory
Symptom relief CompletedWHO: 40 participants with a confirmed diagnosis of Multiple Sclerosis (MS) able to engage in moderate physical activity. WHY: The purpose of this study is to evaluate two computerized brain training tools, which include light physical activity, to see if they can help improve co…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New drug SAR441255 tested in humans for first time
Knowledge-focused CompletedPrimary Objective: To assess the safety and tolerability of SAR441255 after ascending single subcutaneous (SC) doses Secondary Objectives: To assess the pharmacokinetic parameters of SAR441255 in plasma after ascending single SC doses To assess the pharmacodynamic effects on …
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could a lower aspirin dose calm the immune system without increasing bleeding?
Knowledge-focused CompletedHeart attacks are usually caused by clots in a coronary artery, depriving the heart muscle of blood. Platelets are the main type of blood cell causing clots to form and physicians typically give a combination of two anti-platelet drugs, aspirin and ticagrelor, to treat this. Howe…
Phase: PHASE4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:42 UTC
-
New program tackles stigma to keep HIV-Positive men in treatment
Disease control CompletedThis study will implement a pilot randomized controlled trial (RCT, N=60) to assess the feasibility and acceptability a refined emotion regulation intervention designed to improve engagement in HIV-care among substance using HIV+ MSM sub-optimally engaged in HIV care.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Antibiotic levels in lungs: key to better pneumonia treatment?
Knowledge-focused OngoingRespiratory infections are common and sometimes very severe. An insufficient dosage of the antibiotic could lead to a treatment failure A correct plasmatic antibiotic concentration is not a guarantee of a clinical success as it could not be a reflect of pulmonary concentration. T…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Simple quiz could spot Parkinson's pain
Diagnosis CompletedDevelopment and validation of a diagnosis questionnaire of parkinsonian primary pain: the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ)
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Blood test and scan may spot hidden cervical cancer cells
Knowledge-focused Recruiting nowNearly all cervical cancers are caused by the human papilloma virus (HPV), which can be detected in cancer tissue by laboratory tests. There is evidence that the virus can also be detected from a blood sample to monitor the effects of treatment. Previous studies have shown that a…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Which pacing mode works best for heart failure? new study investigates
Knowledge-focused TerminatedCardiac Resynchronization Therapy (CRT) is an established treatment for patients with systolic heart failure and bundle branch block, improving functional capacity, quality of life and reducing morbi-mortality. Adjusting atrio-ventricular (AV) delay, vector optimization and choi…
Phase: NA • Sponsor: CMC Ambroise Paré • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Family genetics study aims to unlock secrets of rare dementia
Knowledge-focused Recruiting nowGENFI Lille is a French cohort that belongs to the international initiative GENFI2, a five year longitudinal biomarker cohort study of genetic FTD and its associated disorders (including MND/ALS) investigating members of families with a known mutation in GRN or MAPT or an expansi…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Magnesium-Rich diet may prevent chemo side effect in ovarian cancer
Prevention OngoingThis trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Promising combo for Triple-Negative breast cancer stalls as trial ends early
Disease control TerminatedThis is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplatin in Patients with CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC). Study population will consist of patients with CCR5-positive, locally advanced or metastatic triple-negative breast cancer (mTNB…
Phase: PHASE1, PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:01 UTC
-
New approach aims to help kids with autism communicate better and reduce dangerous behaviors
Knowledge-focused CompletedThis project examines mechanisms to address two significant challenges present in communication-based behavioral interventions for individuals with autism and comorbid severe destructive behavior (SDB): (a) inflexible communication responding and (b) reemergence of severe destruc…
Phase: NA • Sponsor: State University of New York - Upstate Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Tiny heart probe may predict lung recovery
Knowledge-focused CompletedThe Superior Vena cava Respiratory Collapse Index (cVCS) is a haemodynamic parameter measured exclusively by transoesophageal ultrasound (TEE), which is used to assess cardiac precharge-dependence status. This may be an important prognostic factor in ARDS because it is a sign of …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Researchers dig into thousands of medical records to unlock secrets of prolonged seizures
Knowledge-focused Recruiting nowThe aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC